Imipenem Cilastatin

IMIVIB

COMPOSITION
Imipenem500MG
Cilastatin500MG
SPECIFICATION
FORMINJECTABLE
PACKING 1’s
PACKING TYPE
MRP1690

DESCRIPTION

Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with cilastatin, a renal dipeptidase inhibitor. [PubChem]

SIDE EFFECTS

N/A

INDICATION

For the treatment of bacterial infections caused by susceptible bacteria.